Renue Life Sciences, Inc.
About Renue Life Sciences, Inc.
Renue Life Sciences, Inc. is a Thinkhat life-sciences initiative developing a platform for intelligent medicines aimed at cellular health and age-related disease. The company is presented as a Thinkhat Venture Studio portfolio company focused on advancing next-generation therapeutics. Its site highlights expertise in R&D, translational sciences, CMC, PK/PD, IND-enabling studies, biomarkers, regulatory compliance, and CGT/RNA therapeutics.
Investors
Not disclosed in the source filing. Form D filings do not list investors — StreetZero surfaces them from news where available.
Key highlights
- Developing platform for intelligent medicines targeting cellular health and age-related diseases as a Thinkhat Venture Studio initiative.
- Raised $250,000 through private placement in biotechnology sector.
- Team includes Dr. Phani Kukutla with 15+ years in R&D, translational sciences, and expertise across multiple drug programs.
- Site emphasizes advancing cellular rejuvenation therapies and invites collaboration from researchers, partners, and investors.
Ask StreetZero about Renue Life Sciences, Inc.
Put our AI to work on this deal.
Similar companies
Other Biotechnology deals, ranked by Signal.
Source document & SEC filing
The source SEC filing and the cached document are available to members only. Sign in to view and download them.
Sign in to view the filing Create free account